Compare · AZZ vs EW
AZZ vs EW
Side-by-side comparison of AZZ Inc. (AZZ) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.
Summary
- AZZ operates in Industrials, while EW operates in Health Care - the two are in different parts of the market.
- EW is the larger of the two at $52.38B, about 12.6x AZZ ($4.16B).
- AZZ has been more active in the news (8 items in the past 4 weeks vs 3 for EW).
- EW has more recent analyst coverage (25 ratings vs 14 for AZZ).
- Company
- AZZ Inc.
- Edwards Lifesciences Corporation
- Price
- $138.44-1.58%
- $90.83+0.31%
- Market cap
- $4.16B
- $52.38B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 8
- 3
- Recent ratings
- 14
- 25
AZZ Inc.
AZZ Inc. provides galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, refining, and industrial markets in the United States and internationally. The company operates through two segments, Infrastructure Solutions and Metal Coatings. The Metal Coatings segment offers hot dip galvanizing, powder coating, anodizing, plating, and other metal coating applications to the steel fabrication and other industries. It serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. The Infrastructure Solutions segment provides products and services to support industrial and electrical applications. It offers custom switchgear, electrical enclosures, medium and high voltage bus ducts, explosion proof and hazardous duty lighting, nuclear safety-related equipment, and tubular products, as well as solutions and engineering resources to multi-national companies and small independent companies. This segment sells its products through internal sales force, manufacturers' representatives, distributors, and agents. The company was incorporated in 1956 and is headquartered in Fort Worth, Texas.
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest AZZ
- COO - Metal Coatings Stovall Bryan Lee sold $401,727 worth of shares (2,677 units at $150.07), decreasing direct ownership by 7% to 35,000 units (SEC Form 4)
- Pres & COO - Precoat Metals Vellines Jeffrey sold $647,981 worth of shares (4,220 units at $153.55), decreasing direct ownership by 70% to 1,834 units (SEC Form 4)
- SEC Form 4 filed by Chief Human Resources Officer Davenport Rhonda
- AZZ Inc. Announces August Investor Conference Schedule
- As Wildfires Destroy Communities, Industry Leaders Target a Booming Resilience Market
- New insider Davenport Rhonda claimed no ownership of stock in the company (SEC Form 3)
- AZZ Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- AZZ Inc. Announces the Appointment of Rhonda Davenport as Chief Human Resources Officer
- AZZ Inc. Announces Acquisition of Seattle Galvanizing Company, Inc.
- AZZ Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest EW
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)
- UBS initiated coverage on Edwards Lifesciences with a new price target
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results